Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea flag South Korea · Delayed Price · Currency is KRW
739.00
+59.00 (8.68%)
At close: Jun 17, 2025, 3:30 PM KST

Bridge Biotherapeutics Market Cap

Bridge Biotherapeutics has a market cap or net worth of 43.27 billion as of June 18, 2025. Its market cap has decreased by -17.39% in one year.

Market Cap
43.27B
Enterprise Value
28.96B
Revenue
11.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
739.00

Market Cap Chart

Since December 20, 2019, Bridge Biotherapeutics's market cap has decreased from 300.15B to 43.27B, a decrease of -85.58%. That is a compound annual growth rate of -29.69%.

History

DateMarket Cap% Change
Jun 18, 202543.27B-77.11%
Dec 30, 2024189.04B158.57%
Dec 28, 202373.11B-68.32%
Dec 29, 2022230.80B-17.53%
Dec 30, 2021279.85B0.27%
Dec 30, 2020279.09B-12.04%
Dec 30, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition